BR9711647A - Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os. - Google Patents

Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os.

Info

Publication number
BR9711647A
BR9711647A BR9711647-5A BR9711647A BR9711647A BR 9711647 A BR9711647 A BR 9711647A BR 9711647 A BR9711647 A BR 9711647A BR 9711647 A BR9711647 A BR 9711647A
Authority
BR
Brazil
Prior art keywords
compositions
treatment methods
dicafeoilquímica
derivatives
new
Prior art date
Application number
BR9711647-5A
Other languages
English (en)
Inventor
Junxing Dong
Zhongming Tang
Zhibao Mi
Bingji Wang
Original Assignee
Inst Radiation Med Amms Pla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Radiation Med Amms Pla filed Critical Inst Radiation Med Amms Pla
Publication of BR9711647A publication Critical patent/BR9711647A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"NOVOS DERIVADOS DE áCIDO DICAFEOILQUìMICO, SEU USO, COMPOSIçõES COM OS MESMOS E MéTODOS DE TRATAMENTO USANDO-OS". Esta invenção refere-se ao novo uso de derivados de ácido dicafeoilquínico para tratar Hepatite B e doenças associadas a retrovirus (tal como HIV), os novos derivados de ácido cafeoilquínicos e a composição contendo-os.
BR9711647-5A 1996-08-29 1997-08-27 Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os. BR9711647A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN96111691A CN1087608C (zh) 1996-08-29 1996-08-29 二咖啡酰奎宁酸在治疗乙型肝炎及与逆转录病毒有关疾病中的用途及新咖啡酰奎宁酸衍生物
PCT/CN1997/000087 WO1998009599A2 (fr) 1996-08-29 1997-08-27 Utilisation d'un nouvel acide bicafeoylquinique dans le traitement de l'hepatite b et des maladies liees a des retrovirus, et derives de cet acide bicafeolyquinique

Publications (1)

Publication Number Publication Date
BR9711647A true BR9711647A (pt) 2000-06-06

Family

ID=5121229

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711647-5A BR9711647A (pt) 1996-08-29 1997-08-27 Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os.

Country Status (8)

Country Link
US (1) US6331565B1 (pt)
EP (1) EP1008344B1 (pt)
JP (1) JP4219986B2 (pt)
CN (1) CN1087608C (pt)
AU (1) AU4008597A (pt)
BR (1) BR9711647A (pt)
DE (1) DE69734296T2 (pt)
WO (1) WO1998009599A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1093529C (zh) * 1999-04-16 2002-10-30 中国人民解放军军事医学科学院放射医学研究所 1，5－二－o－咖啡酰奎宁酸衍生物的制备方法
US20040002423A1 (en) * 2000-04-10 2004-01-01 Hiromu Ohnogi Remedies
US6632459B2 (en) * 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
CN100353938C (zh) * 2004-09-29 2007-12-12 中国人民解放军军事医学科学院放射与辐射医学研究所 含二咖啡酰奎尼酸的组合物及其制备方法
CN100341500C (zh) * 2004-09-29 2007-10-10 中国人民解放军军事医学科学院放射与辐射医学研究所 含二咖啡酰奎尼酸的乳剂及其制备方法
EP1671535A1 (en) 2004-12-16 2006-06-21 Stiftung Caesar Center of Advanced European Studies and Research Methods for altering levels of phenolic compounds in plant cells
JP4586119B2 (ja) * 2005-10-28 2010-11-24 独立行政法人科学技術振興機構 Ｃ型肝炎ウイルス産生抑制材料とその製法
CN1899279A (zh) * 2005-07-22 2007-01-24 四川九章生物化工科技发展有限公司 绿原酸在制备具有保护肝脏功效药物的用途
CN1879727B (zh) * 2006-05-09 2010-04-21 中国科学院上海药物研究所 新型抗乙肝病毒抑制剂及其应用
CN101185668A (zh) * 2006-11-15 2008-05-28 广州联创思远利生物科技有限公司 一种新的防治艾滋病及保肝解毒制剂
JP4621855B2 (ja) * 2007-01-17 2011-01-26 雲海酒造株式会社 肝臓保護剤、肝がん発症抑制剤、及びそれらの医薬組成物
CN101245068A (zh) 2007-02-14 2008-08-20 浙江医药股份有限公司新昌制药厂 结晶型态的恩替卡韦及其制备方法和其药物组合物及用途
CN101284799B (zh) * 2007-03-23 2013-04-03 浙江医药股份有限公司新昌制药厂 咖啡酰奎宁酸含氮衍生物及其制备方法和其药物组合物及用途
CN101397333A (zh) 2007-09-27 2009-04-01 浙江医药股份有限公司新昌制药厂 去羟基万古霉素及其制备方法、和其药物组合物及其用途
FR2926955B1 (fr) 2008-02-01 2012-07-20 Agronomique Inst Nat Rech Procede de preparation d'acides dicafeoylquiniques et leur utilisation dans la lutte contre les pucerons
CN101828693B (zh) 2009-03-09 2013-01-02 浙江医药股份有限公司新昌制药厂 制备低粘度高流动性类胡萝卜素油悬浮液的方法及其应用
CN101829077B (zh) * 2010-05-26 2012-01-18 中国药科大学 二咖啡酰奎尼酸衍生物在制备用于治疗支原体感染疾病药物中的用途
CN114652710A (zh) * 2022-04-01 2022-06-24 北京济全生物科技有限公司 1,3-二咖啡酰奎宁酸在用于制备治疗肝癌的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1050371B (it) * 1973-07-05 1981-03-10 Simes Composizione farmaceutica per il trattamento delle malattie del fegato
US6355684B1 (en) * 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
FR2693105B1 (fr) * 1992-07-01 1994-09-02 Oreal Composition cosmétique et/ou dermatologique à action dépigmentante contenant un acide di- ou tri-caféoylquinique ou un mélange de ceux-ci.

Also Published As

Publication number Publication date
EP1008344A4 (en) 2003-09-17
AU4008597A (en) 1998-03-26
EP1008344B1 (en) 2005-09-28
DE69734296T2 (de) 2006-07-06
CN1175411A (zh) 1998-03-11
WO1998009599A3 (fr) 1998-06-04
WO1998009599A2 (fr) 1998-03-12
CN1087608C (zh) 2002-07-17
JP2000517323A (ja) 2000-12-26
EP1008344A2 (en) 2000-06-14
US6331565B1 (en) 2001-12-18
JP4219986B2 (ja) 2009-02-04
DE69734296D1 (de) 2006-02-09

Similar Documents

Publication Publication Date Title
BR9711647A (pt) Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os.
MX9700237A (es) Combinaciones inhibidoras de proteasa retroviral.
DE69811062D1 (de) Polyaromatische antivirale zusammensetzungen
BRPI9917007B8 (pt) azabicicloalcanos como moduladores de ccr5, composição farmacêutica contendo os mesmos, bem como seu uso
PT735890E (pt) Misturas de 2',3'-didesoxi-inosina e hidroxicarbamida para inibicao da disseminacao retroviral
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
DE69518840D1 (en) N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
GR1001511B (el) Στεροειδείς συν?έσεις.
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
ES2129893T3 (es) Dinucleosido-5',5'-pirofosfatos.
NO941097L (no) Hudregenererende kosmetisk preparat
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
DE3560313D1 (en) Improvements in or relating to anticonvulsant agents
BR0009194A (pt) Composição do resorcinol
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
ATE142075T1 (de) Wirkstoff zur bekämpfung von viren der retrovirengruppe, diesen enthaltende zusammensetzungen und deren verwendungen
ES2150034T3 (es) Empleo de las 2-aminotetralinas substituidas en 6,7 para la preparacion de composiciones farmaceuticas de utilidad para el tratamiento del choque septico, y composiciones farmaceuticas antipireticas y antiinflamatorias.
BR9708720A (pt) Composição farmacêutica e processo para o tratamento de demência por hiv.
FI943295A (fi) Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit
EP0335426A3 (en) Compositions and process for protecting t lymphocytes against the etiological agent of lymphadenopathy and acquired immunodepression syndrom
PT958290E (pt) Derivados de 1,4-di-hidropiridina e seu uso em terapia
MY117535A (en) Hiv protease inhibitors

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]